Company profile
Biotesserae Camunity company profile
Biotesserae Camunity is a nanobody-based platform for the production of a new class of therapeutics for canine cancer. The company was formed by Chris Cebra, chair of the Department of Clinical Sciences, and colleagues Shay Bracha, Dan Mourich, and Carl Ruby.
Business identity
- Website
- https://www.biotesserae.com
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2016-10-25
Headquarters
- Headquarters
- Grants, New Mexico, United States
- Country code
- US
- Continent
- North America